# Infant Nasal Nitric Oxide Levels in Congenital Heart Disease

> **NCT02551107** · NA · TERMINATED · sponsor: **University of Alberta** · enrollment: 67 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DEVICE:** Measurement of nasal Nitric Oxide level

## Key facts

- **NCT ID:** NCT02551107
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2018-01-12
- **Final completion:** 2018-01-12
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Inadequate resources
- **Last updated:** 2018-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551107, "Infant Nasal Nitric Oxide Levels in Congenital Heart Disease". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02551107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*